The Fertility Hub are delighted to be the media partner for the upcoming Women’s Health Study Day for healthcare professionals. Organised by the Fertility Team at West Herts Hospital NHS Trust and Herts Fertility. This online study day takes place on Saturday 26 September 2020. The study day is aimed at doctors, nurses, embryologists, midwives, trainees, GP’s and all other healthcare professionals working in women’s healthcare.
Mr. Raj Mathur, Fertility Consultant, St Mary’s Hospital, Manchester University NHS Foundation Trust.
One of the distinguished speakers is Mr. Raj Mathur who is a Consultant Gynaecologist and Subspecialist in Reproductive Medicine and Surgery at Manchester University NHS Trust. He has a long-standing research interest in Ovarian Hyperstimulation Syndrome (OHSS). He is the lead author of the current Royal College of Obstetricians and Gynaecology and British Fertility Society (BFS) guidelines on OHSS. Mr. Mathur is an External Advisor to the Human Fertilisation and Embryology Authority Scientific and Clinical Advances Advisory Committee. He is Chair-Elect of the BFS.
He will present on Polycystic Ovary Syndrome (PCOS) and OHSS. PCOS is the commonest cause of anovulation. Sub fertile couples where the woman has an ovulation due to PCOS should be fully evaluated to plan treatment. Lifestyle advice, including weight management through a combination of calorie restriction and exercise is an effective way of improving fertility, but requires support and resources to empower patients. Clomifene is the most commonly used first line ovulation induction agent, but meta-analysis evidence supports the use of Letrolozole in reference to Clomifene. In women receiving clomifene, Metformin is associated with a shorter time to conception. If first line medical treatment fails, both laparoscopic ovarian diathermy and gonadotropin ovulation induction have similar efficacy. However, ovarian diathermy is more invasive, while gonadotropin administration carries a risk of multiple pregnancy and hyperstimulation.
Ovarian Hyperstimulaion Syndrome (OHSS) is an iatrogenic condition arising from inflammatory mediators produced by ovaries in response to FSH stimulation followed by HCG action. It is characterised by ovarian enlargement and fluid shift out of the vascular system and into the third space. Even in modern fertility practice, where GnRH antagonist regimes are predominantly used, OHSS remains a risk with a typical incidence of 1.6%. Preventative measures include GnRH antagonist regime, lower starting dose of FSH, agonist trigger and elective freeze-all of embryos. Management of OHSS focuses on establishing the correct diagnosis, providing pain relief, encouraging oral intake guided by thirst, thrombo-prophylaxis and drainage of ascites. Evidence suggests that earlier drainage of ascites is associated with a more rapid resolution of OHSS, and the STOP OHSS trailing the UK is examining whether this can be integrated into UK practice.
Mr. George Soulakis, Speciality Trainee, West Herts Hospital NHS Trust – Audit of the fertility services
Mr. Himanshu Borase, Lead Fertility Consultant, West Herts Hospital NHS Trust – Career opportunities in Fertility, UK and International Trainees
Ms. Garima Srivastava, Fertility Consultant, Homerton University Hospital NHS Foundation Trust – 3D ultrasound in Infertility
Prof. Geeta Nargund, Founder, Medical Director, Create IVF, London, President ISMAAR – Mild Approaches in IVF
Mr. Cesar Diaz, Fertility Consultant, IVI London – PGT and PGS updates
Mr. Robert Milnes, CEO, Fertility Focus – Remote screening and monitoring for sub-fertility issues and treatment with continuous core body temperature
Dr. James Barrett, Lead Clinician, Gender Identity Clinic, London – Transgender Fertility
Ms. Barbara Scott, Reflexologist – Reproductive Reflexology Methodology and Data
Mr. Raj Mathur, Fertility Consultant, St Mary’s Hospital, Manchester University NHS Foundation Trust – PCOS and OHSS updates
Ms. Saghar Kasiri, Cryos, Denmark – Gamete Donation updates
Short oral presentation of the award-winning posters
Please click here to register. Places cost £50 for GPs and Consultants. £25 for fertility nurses, embryologists and other assisted reproduction professionals.